Previous close | 210.21 |
Open | 210.74 |
Bid | 160.00 x 800 |
Ask | 234.60 x 800 |
Day's range | 210.16 - 214.10 |
52-week range | 192.40 - 255.93 |
Volume | |
Avg. volume | 499,269 |
Market cap | 21.407B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 55.99 |
EPS (TTM) | 3.82 |
Earnings date | 31 Oct 2022 - 04 Nov 2022 |
Forward dividend & yield | 1.88 (0.90%) |
Ex-dividend date | 06 Sept 2022 |
1y target est | 239.50 |
Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.
STERIS' (STE) revenues at AST improve driven by increased demand from medical device and biopharma customers.
Steris (STE) delivered earnings and revenue surprises of 0% and 5.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?